Kovina Therapeutics
PrivateLast Round
Grant
Nov 2, 2022
Total Funding Raised
$4.98M
Company Overview
Kovina Therapeutics is a biotechnology company developing first-in-class small molecule antiviral therapies to treat cancers and pre-malignant infections caused by Human Papillomavirus (HPV).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kovina Therapeutics Comparables
Compare Kovina Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Toragen, Inc. | 84% | |
| Antiva Biosciences | 77% | |
| Loma Therapeutics | 77% | |
Kovina Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 2, 2022 | ||||
| Grant | Sep 13, 2022 | ||||
| Grant | Jun 18, 2022 | ||||
| Seed | Oct 20, 2021 |
Key People
Founding team and executive leadership
Kovina Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| Elevate Ventures | Seed |
| BioCrossroads | Seed |
| IU Ventures | Seed |
| National Institute of Dental and Craniofacial Research | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2025
Monthly visitors grew 597% MoM, from 237 to 1.7K.
- Oct 28, 2024
Monthly visitors grew 40% MoM, reaching 1K.
Kovina Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kovina Therapeutics's valuation, stock price, and market status.